Reach Us +1-947-333-4405
Editor - Qingdi Quentin Li | National Institutes of Health | 2107
ISSN: 2157-2518

Journal of Carcinogenesis & Mutagenesis
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Qingdi Quentin Li

Qingdi Quentin Li
Qingdi Quentin Li
National Institute of Allergy and Infectious Diseases
National Institutes of Health
Tel: 301-208-1945
National Institutes of Health


Q Quentin Li is a Senior Staff Biologist at the National Institutes of Health and was an Assistant Professor at the Mary Babb Randolph Cancer Center West Virginia University Robert C Byrd Health Sciences Center. He was a Guest Professor/Visiting Professor for six reputed universities in China. He obtained an MD from China and worked as Dermatologist at Sun YatSen University School of Medicine. He also received his MS in Microbiology Immunology and PhD in Pharmacology and Experimental Therapeutics from the University of Maryland School of Medicine with postdoctoral training in Molecular and Cell Biology of Cancer in Medical Oncology Branch. He is a member of the American Association for Cancer .He served as Principal Investigator on several grants funded by the National Institutes of Health and a pharmaceutical company.  He serves in the Editorial Board of two journals and is a reviewer for 14 scientific journals and a research development foundation He has authored over 80 peer reviewed research articles and reviews and presented more than 50 papers at national and international scientific meetings.

Research Interest

Molecular & cell biology of cancer; Oncopharmacology & cancer chemotherapy; New anti-tumor drug research & development; Natural products as novel anti-cancer agents; Apoptosis & cell cycle control in cancer cells; DNA repair capacity & platinum drug resistance in human carcinomas; Epigenetic modulation of DNA damage responses and DNA repair; Identification of biomarkers and epigenetic markers for diagnosis and treatment of carcinomas; Epigenetic regulation of gene expression in T-cells and leukemic cells; Interface between angiogenesis and platinum sensitivity; Platinum and taxol drug resistance in lung cancer, ovarian cancer, bladder cancer, and other types of solid tumors.



Global Speakers in the subject

Global Experts in the subject